Therefore, the novel 5-pentynecarbonyl-octreotide-conjugated liposomal paclitaxel presents a promising delivery system specific to pancreatic cancer cells and tissues with high expression of SSTR2. This evidence concerns the gene SSTR2 and familial pancreatic carcinoma.